These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7690355)

  • 1. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma.
    Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y
    Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
    Kuraya M; Yefenof E; Klein G; Klein E
    Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
    Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
    Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-regulatory proteins in ovarian malignancies.
    Bjørge L; Hakulinen J; Wahlström T; Matre R; Meri S
    Int J Cancer; 1997 Jan; 70(1):14-25. PubMed ID: 8985085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF.
    Hara T; Matsumoto M; Fukumori Y; Miyagawa S; Hatanaka M; Kinoshita T; Seya T; Akedo H
    Immunol Lett; 1993 Aug; 37(2-3):145-52. PubMed ID: 7505002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the complement regulatory proteins in the normal human kidney.
    Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S
    Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion.
    Jensen TS; Bjørge L; Wollen AL; Ulstein M
    Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms.
    Sayama K; Shiraishi S; Miki Y
    Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
    Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
    Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells.
    Marschang P; Gürtler L; Tötsch M; Thielens NM; Arlaud GJ; Hittmair A; Katinger H; Dierich MP
    AIDS; 1993 Jul; 7(7):903-10. PubMed ID: 7689323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
    Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract.
    Berstad AE; Brandtzaeg P
    Gut; 1998 Apr; 42(4):522-9. PubMed ID: 9616315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
    Simpson KL; Houlihan JM; Holmes CH
    Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
    Simpson KL; Holmes CH
    Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland.
    Bardenstein DS; Dietz Y; Lass JH; Medof ME
    Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.